Schedule 13D ownership disclosure
REVIVA PHARMACEUTCLS HLDGS I
Security class unavailable · CUSIP: 76152G100
Event date: 2021-06-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-181486
- Form type
- SC 13D
- Filer
- REVIVA PHARMACEUTICALS HOLDINGS, INC.
- CIK
- CIK 1742927
- Filed
- Jun 03, 2021
- Reporting period
- Jun 01, 2021
- Description
- Schedule 13D beneficial ownership